Cargando…

Future therapeutic targets in rheumatoid arthritis?

Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by persistent joint inflammation. Without adequate treatment, patients with RA will develop joint deformity and progressive functional impairment. With the implementation of treat-to-target strategies and availability of biolo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheung, Tommy Tsang, McInnes, Iain B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486796/ https://www.ncbi.nlm.nih.gov/pubmed/28451787 http://dx.doi.org/10.1007/s00281-017-0623-3

Ejemplares similares

Interleukin-18: a therapeutic target in rheumatoid arthritis?
por: McInnes, Iain B, et al.
Publicado: (2005)

JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
por: Fragoulis, George E, et al.
Publicado: (2019)

Immune-mediated inflammatory disease therapeutics: past, present and future
por: McInnes, Iain B., et al.
Publicado: (2021)

Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis
por: Welsh, Paul, et al.
Publicado: (2016)

Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells
por: Alivernini, S., et al.
Publicado: (2018)

DNA Methylation as a Future Therapeutic and Diagnostic Target in Rheumatoid Arthritis
por: Ciechomska, Marzena, et al.
Publicado: (2019)

Identification of Urinary Peptide Biomarkers Associated with Rheumatoid Arthritis
por: Stalmach, Angelique, et al.
Publicado: (2014)

Synovial Tissue Response to Treatment in Psoriatic Arthritis
por: Codullo, Veronica, et al.
Publicado: (2011)

Looking through the 'window of opportunity': is there a new paradigm of podiatry care on the horizon in early rheumatoid arthritis?
por: Woodburn, James, et al.
Publicado: (2010)

Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis
por: Jongbloed, Sarah L, et al.
Publicado: (2006)

Long-term study of the impact of methotrexate on serum cytokines and lymphocyte subsets in patients with active rheumatoid arthritis: correlation with pharmacokinetic measures
por: Kremer, Joel M, et al.
Publicado: (2016)

IL-23 orchestrating immune cell activation in arthritis
por: Najm, Aurélie, et al.
Publicado: (2021)

Neutropaenia in early rheumatoid arthritis: frequency, predicting factors, natural history and outcome
por: Fragoulis, George E, et al.
Publicado: (2018)

Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis
por: Carini, Claudio, et al.
Publicado: (2018)

Erratum to: Secukinumab: A New Treatment Option for Psoriatic Arthritis
por: Mease, Philip, et al.
Publicado: (2016)

Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
por: Ogdie, Alexis, et al.
Publicado: (2020)

Possible Future Avenues for Rheumatoid Arthritis Therapeutics: Hippo Pathway
por: Wang, Tao, et al.
Publicado: (2023)

Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis
por: Gabay, Cem, et al.
Publicado: (2016)

Depression and anxiety in an early rheumatoid arthritis inception cohort. associations with demographic, socioeconomic and disease features
por: Fragoulis, George E, et al.
Publicado: (2020)

How does age determine the development of human immune-mediated arthritis?
por: Degboe, Yannick, et al.
Publicado: (2022)

Association of central adiposity with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional study of the UK Biobank
por: Ferguson, Lyn D, et al.
Publicado: (2019)

Immunophenotype and functional characteristics of rheumatoid arthritis derived myeloid dendritic cells and plasmacytoid dendritic cells
por: Jongbloed, S, et al.
Publicado: (2005)

MicroRNA-155 regulates monocyte chemokine and chemokine receptor expression in Rheumatoid Arthritis
por: Elmesmari, Aziza, et al.
Publicado: (2016)

Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial
por: Siebert, Stefan, et al.
Publicado: (2020)

Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
por: Burmester, Gerd R, et al.
Publicado: (2013)

Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis
por: Kerschbaumer, Andreas, et al.
Publicado: (2020)

The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
por: McGonagle, Dennis G, et al.
Publicado: (2019)

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
por: Dayer, Jean-Michel, et al.
Publicado: (2010)

Can Metabolic Pathways Be Therapeutic Targets in Rheumatoid Arthritis?
por: Sanchez-Lopez, Elsa, et al.
Publicado: (2019)

Adipokines in Rheumatoid Arthritis: Emerging Biomarkers and Therapeutic Targets
por: Bilski, Jan, et al.
Publicado: (2023)

MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
por: Charles-Schoeman, Christina, et al.
Publicado: (2023)

Brief Report: Proatherogenic Cytokine Microenvironment in the Aortic Adventitia of Patients With Rheumatoid Arthritis
por: Ahmed, Ammad, et al.
Publicado: (2016)

Characteristics of rheumatoid arthritis and its association with major comorbid conditions: cross-sectional study of 502 649 UK Biobank participants
por: Siebert, Stefan, et al.
Publicado: (2016)

A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis
por: Weinblatt, Michael E., et al.
Publicado: (2017)

Treating rheumatoid arthritis to target: recommendations of an international task force
por: Smolen, Josef S, et al.
Publicado: (2010)

Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets
por: Alunno, Alessia, et al.
Publicado: (2017)

RANKL is a therapeutic target of bone destruction in rheumatoid arthritis
por: Tanaka, Sakae
Publicado: (2019)

Cascade Processes with Micellar Reaction Media: Recent Advances and Future Directions
por: Tang, Christina, et al.
Publicado: (2022)

Promoter polymorphisms in the IL-18 gene are associated with rheumatoid arthritis in two independent clinical cohorts
por: Gracie, JA, et al.
Publicado: (2003)

The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases
por: Gabay, Cem, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_nl1ujnh6kt1pbvs4tik4631es6